Sanofi and Aviesan Renew French Agreement
Sanofi and Aviesan Renew their Agreement to Accelerate Research in France
-Three-year renewal of the cooperation protocol-
Paris, France-September 27, 2013- Sanofi (EURONEXT: SAN and NYSE: SNY) and Aviesan 1, the French National Alliance for Life Sciences and Health today announced that they have renewed for a period of three years the cooperation protocol signed in 2010. The aim is to contribute to the development of new treatments that target unmet medical needs, including those in the field of rare diseases, to participate to the excellence and consolidation of research in French industry on an international level. Special emphasis will be put on translational research projects that bring together clinical and medical teams with fundamental research teams to translate research successes in to medical advances.
Posted: September 2013